J. I. Udo de Haes

5-HT(1A) receptor imaging in the human brain: effect of tryptophan depletion and infusion on [(18)F]MPPF binding.

Jan Pruim, J. Pruim, A. van Waarde, 2002, Synapse.

Effect of fenfluramine‐induced increases in serotonin release on [18F]MPPF binding: A continuous infusion PET study in conscious monkeys

N. Harada, H. Tsukada, P. Elsinga, 2006, Synapse.

Methylphenidate-induced changes in regional cerebral blood flow: A [15O]H2O PET study in healthy volunteers

A. Paans, J. D. den Boer, P. Maguire, 2005 .

Early stage development of the glycine-1 re-uptake inhibitor SCH 900435: central nervous system effects compared with placebo in healthy men.

J. V. van Gerven, G. Holder, M. D. de Kam, 2013, British journal of clinical pharmacology.

5-Hydroxytryptamine1A receptor occupancy by novel full antagonist 2-[4-[4-(7-chloro-2,3-dihydro-1,4-benzdioxyn-5-yl)-1-piperazinyl]butyl]-1,2-benzisothiazol-3-(2H)-one-1,1-dioxide: a[11C][O-methyl-3H]-N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide trihydrochlori

F. Turkheimer, P. Grasby, E. Rabiner, 2002, The Journal of pharmacology and experimental therapeutics.

Pharmacokinetics of sugammadex in subjects with moderate and severe renal impairment
.

K. Lasseter, T. Marbury, R. Wrishko, 2017, International journal of clinical pharmacology and therapeutics.

A randomised trial of the effect of the glycine reuptake inhibitor Org 25935 on cognitive performance in healthy male volunteers

D. Nutt, Sue J. Wilson, D. Christmas, 2014, Human psychopharmacology.

Design, synthesis and structure-activity relationships of (indo-3-yl) heterocyclic derivatives as agonists of the CB1 receptor. Discovery of a clinical candidate.

R. Bursi, M. Deehan, Paul J. Harradine, 2011, Bioorganic & medicinal chemistry letters.